EFDID: 511523EFD: View Filing

Issuer: Adverum Biotechnologies, Inc. (0001501756) - D

Accession: 0002010585-24-000002 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001501756
  • Entity Name:
    Adverum Biotechnologies, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    100 CARDINAL WAY
    REDWOOD CITY, CA 94063
  • Persons:
    Related Persons 13
    Laurent Fischer
    Executive Officer, Director
    Linda Rubinstein
    Executive Officer
    Patrick Machado
    Director
    Soo Hong
    Director
    Mark Lupher
    Director
    C. David Nicholson
    Director
    Rabia Gurses Ozden
    Director
    James Scopa
    Director
    Dawn Svoronos
    Director
    Reed Tuckson
    Director
    Scott Whitcup
    Director
    Setareh Seyedkazemi
    Executive Officer
    Kishor Peter Soparkar
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    02/21/2024
  • First Sale Date:
    02/07/2024
  • Offering Amount:
    $127,800,000
  • Amount Sold:
    $127,800,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Cowen and Company, LLC 7616 None None CA, NY
Truist Securities, Inc. 6271 None None CA, NY
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Adverum Biotechnologies, Inc./s/ Linda RubinsteinLinda RubinsteinChief Financial Officer2024-02-21